Glucagon-like peptide-1 receptor agonist
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Glucagon-like peptide-1 receptor agonist, covering 2017-01-12 to 2025-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment [Phase 3]